Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS are more likely to have thyroid antibodies than those without.

A woman with a rare hormone resistance condition also had missing teeth and hair loss, which might be new symptoms of her genetic disorder.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

PCOS is a common and costly condition in North American women, causing various health issues like obesity, diabetes, and fertility problems.

A 19-year-old male with delayed puberty was successfully treated for a condition that prevents normal hormone production.

Telogen effluvium is a type of hair loss in women caused by many factors, and iron and thyroid tests are recommended for diagnosis.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Male hormones control a specific gene in hamster skin, with different hormones having varying effects.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Non-classic congenital adrenal hyperplasia (NCCAH) can mimic PCOS and requires genetic testing for proper diagnosis and treatment.

Human skin cells contain Protease Nexin-1, and male hormones can decrease its levels, potentially affecting hair growth.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Recognizing macro-TSH is crucial to avoid unnecessary treatments.

A new plant extract from Avicennia marina could potentially be used to treat common hair loss.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

The document concludes that thyroid disorders in children require specific treatments and monitoring, and educational resources are available for further information.

A multidisciplinary approach is crucial for managing Silver-Russell syndrome effectively.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

ABCD1 gene mutations cause adrenomyeloneuropathy, leading to symptoms like limb weakness and spasticity, with management focusing on rehabilitation and spasticity treatment.

Finasteride treats hair loss but may cause side effects like low libido and dizziness.

Biotin can interfere with lab tests, causing misdiagnosis.

The document concludes that hair is complex, with a detailed growth cycle, structure, and clinical importance, affecting various scientific and medical fields.

Over a third of women thought to have non-classical congenital adrenal hyperplasia didn't have it confirmed by genetic tests.

The 39th Manfred Donike Workshop discussed methods for detecting misuse of steroids, gene doping, and the complexity of identifying drug residues in urine, highlighting the ongoing efforts to improve global anti-doping work.

Finasteride can reduce fertility in some men, but stopping it increases sperm count.

The exact cause of growth hormone-responsive alopecia in dogs is unclear.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.